Biotricity 10-K: Going Concern Warning Despite Operating Turnaround; 1-for-100 Reverse Split Pending

summarizeSummary

Biotricity reported its first operating profit but auditors flagged a going concern risk. A 1-for-100 reverse stock split is pending, adding uncertainty for shareholders.

check_boxKey Events · Earnings and Guidance · BTCY

• Going Concern Warning

  Auditors expressed substantial doubt about Biotricity's ability to continue as a going concern, citing a $31.3M working capital deficit, $142.6M accumulated deficit, and only $149,789 in cash.

• First Operating Profit

  The company achieved operating income of $1.7M for fiscal 2026, a $4.1M improvement from the prior year's $2.4M loss, driven by 16% revenue growth to $16.0M and cost controls.

• Net Loss Narrows

  Net loss attributable to common stockholders fell to $3.1M ($0.115 per share) from $11.9M ($0.555 per share), aided by lower operating expenses and reduced non-cash charges.

• 1-for-100 Reverse Stock Split Approved

  A 1-for-100 reverse stock split has been approved by the board and majority stockholders, with an information statement filed. The split is expected to reduce outstanding shares from ~20.1M to ~201,000.

auto_awesomeAnalysis · BTCY · Industrial Applications And Services

Biotricity's annual report reveals a stark contrast: the company achieved its first operating profit of $1.7 million on 16% revenue growth, yet auditors issued a going concern warning due to a $31.3 million working capital deficit and just $149,789 in cash. The net loss narrowed sharply to $3.1 million from $11.9 million, but the balance sheet remains precarious. Against this backdrop, a 1-for-100 reverse stock split has been approved, a move that could dramatically alter the share structure and is likely aimed at regaining Nasdaq compliance. The filing also discloses 20.1 million shares outstanding, setting the stage for significant post-split adjustments.